NCT04031872 2025-09-05
LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)
The Netherlands Cancer Institute
Phase 1/2 Withdrawn
Clinical Trials
5 trialsNCT04751955 2023-10-31
A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)
Korean Cancer Study Group
Phase 1/2 Withdrawn
NCT05062720 2022-12-09
Local Consolidative Therapy in Colorectal Cancer
Fox Chase Cancer Center
Phase 2 Withdrawn
NCT03470350 2019-07-24
EORTC1615
The Netherlands Cancer Institute
Phase 1/2 Withdrawn
NCT02085005 2014-11-18
Drop and Go
Sanofi
Phase 2 Withdrawn